BPC-157 has been shown to accelerate the healing of muscles, tendons, ligaments and inflammatory bowel disorders such as ulcers, leaky gut, and Crohn’s disease.
BPC-157 is a penta-decapeptide composed of 15 amino acids. It is a partial sequence of the body protection compound (BPC) that was discovered in and isolated from human gastric juice. Animal studies have shown it to accelerate the healing of many different wounds, including muscle, tendon and damaged ligaments. Additionally, BPC 157 has shown to protect organs and aids in the prevention of gastric ulcers. BPC-157 acts systemically in the digestive tract to combat leaky gut, IBS, gastro-intestinal cramps, and Crohn’s disease. This peptide has been known to exhibit analgesic characteristics. Research has shown its ability to help skin burns heal at a faster rate by increasing blood flow to damaged tissues. BPC-157 significantly accelerates reticulin and collagen formation as well as angiogenesis together with stimulation of macrophages and fibroblasts infiltration representing a potential therapeutic tool in wound healing management.
Research
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a portion of the protein known as BPC, which has been studied for its potential therapeutic effects, particularly in tissue repair and gastrointestinal health. Here are some studies and sources related to BPC-157:
The gastric pentadecapeptide BPC 157 promotes healing of colonic anastomosis in rats.
Published in the Journal of Physiology, Paris in 1995, this study investigates the effects of BPC-157 on the healing of colonic anastomosis in rats.
Effects of pentadecapeptide BPC 157 on gastrointestinal lesions induced by 90 minutes of complete occlusion of superior mesenteric artery in rats.
Published in the Journal of Physiology, Paris in 1994, this study examines the effects of BPC-157 on gastrointestinal lesions induced by complete occlusion of the superior mesenteric artery in rats.
BPC 157 therapy to detriment sphincters failure after ileoileal anastomosis in rat.
Published in the Life Sciences journal in 1994, this study evaluates the effects of BPC-157 therapy on sphincter failure after ileoileal anastomosis in rats.
The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity.
Published in the Journal of Physiology, Paris in 1994, this study investigates the effects of BPC-157 on various types of pain and capsaicin neurotoxicity.
Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat.
Published in the Surgery journal in 1995, this study examines the efficacy of BPC-157 therapy in muscle crush injury in rats.
These studies provide insights into the potential therapeutic applications of BPC-157, particularly in promoting tissue healing and gastrointestinal health in animals. As with any research, it’s important to consider the credibility of the sources and consult with healthcare professionals for personalized advice or treatment recommendations.
Reviews
There are no reviews yet.